Virtual reality and dye for lung surgery
Part of Cancer, Lungs & breathing clinical trials.
This study tests a new way to help surgeons remove lung cancer more precisely using virtual reality and a special dye. It might help ensure the cancer is fully removed while saving as much healthy lung as possible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your lung tumor must be smaller than 3 centimeters.
- You must have early-stage lung cancer that has not spread.
- Your tumor must be located in one section of the lung that can be removed surgically.
- You cannot be allergic to the dye used in the procedure or to iodine.
- If you are pregnant, breastfeeding, or could become pregnant, you must not participate or must use birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to plan and guide lung cancer surgery using a special dye that shows the tumor area during the operation. It may help surgeons remove the cancer more accurately while targeting only a small section of lung for certain early-stage patients.
This early-stage trial tests a robotic lung surgery that uses a special dye with near-infrared light to help the surgeon remove only the tumor area. If you have a small, early lung cancer, this approach may help improve accuracy while limiting how much lung is removed.
This study tests whether 3D models made from non-contrast CT scans are accurate enough to guide minimally invasive lung segmentectomy (removing a small piece of the lung) for early-stage lung cancer. It may help certain patients avoid the need for contrast dye.
This trial uses 3D models from your CT scan to help doctors predict how well your lungs will work after surgery. It is for people having a certain type of lung surgery (VATS) to remove part of a lung.
This trial tests a special imaging technique that uses a harmless dye to help surgeons see the exact boundary between healthy and diseased lung tissue during surgery to remove a small part of the lung. This could help make the surgery more precise and potentially preserve more healthy lung.
This trial tests a single dose of a special dye (LS301-IT) that helps surgeons see lung cancer cells more clearly during surgery. It aims to make lung cancer removal more precise and complete.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.